Illinois Municipal Retirement Fund’s Neurocrine Biosciences NBIX Stock Holding History

Illinois Municipal Retirement Fund’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,046	Closed	-$1.37M	–	1361
2024 Q4	$1.37M	Hold	10,046	–	–	0.02%	789
2024 Q3	$1.16M	Hold	10,046	–	–	0.02%	869
2024 Q2	$1.38M	Hold	10,046	–	–	0.02%	733
2024 Q1	$1.39M	Hold	10,046	–	–	0.02%	738
2023 Q4	$1.32M	Hold	10,046	–	–	0.02%	732
2023 Q3	$1.13M	Hold	10,046	–	–	0.02%	743
2023 Q2	$947K	Hold	10,046	–	–	0.02%	654
2023 Q1	$1.02M	Buy	+10,046	New	+$1.05M	0.02%	622
2021 Q2	–	Sell	-18,157	Closed	-$1.77M	–	867
2021 Q1	$1.77M	Sell	18,157 -7,227	-28%	-$758K	0.08%	298
2020 Q4	$2.43M	Buy	25,384 +16,974	+202%	+$1.64M	0.11%	241
2020 Q3	$809K	Buy	8,410 +1,692	+25%	+$196K	0.11%	250
2020 Q2	$820K	Buy	+6,718	New	+$742K	0.34%	131

Other funds holding NBIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Illinois Municipal Retirement Fund's NBIX Position: Q1 2025 in Review

Illinois Municipal Retirement Fund sold out of Neurocrine Biosciences (NBIX) in Q1 2025, closing a stake of 10,046 shares — an estimated $1.37M sold.

Illinois Municipal Retirement Fund first reported a position in NBIX in Q2 2020 and held it in 12 quarters. The position peaked at $2.43M in Q4 2020. 587 funds tracked by Wall St. Rank hold NBIX as of Q1 2025.

Illinois Municipal Retirement Fund reported no remaining Neurocrine Biosciences position as of Q1 2025 after selling out during the quarter.
Illinois Municipal Retirement Fund sold 10,046 Neurocrine Biosciences shares in Q1 2025, an estimated $1.37M.
Illinois Municipal Retirement Fund first reported a position in Neurocrine Biosciences in Q2 2020 and held it in 12 quarters.
Illinois Municipal Retirement Fund's Neurocrine Biosciences position peaked at $2.43M in Q4 2020.
587 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2025.

Based on Illinois Municipal Retirement Fund's 13F filing for Q1 2025, filed 24 Apr 2025.